# Tumor PD-L1 and lymphocytic infiltrate CD8 and FOXP3 status in primary and metastatic papillary renal cell carcinoma

**Authors:** Marie-Lisa Eich MD (1), Gunes Guner MD (2), María del Carmen Rodriguez Peña MD (1), María Angélica Mendoza Rodríguez MD (2), Margret Cocks MD (2), Diana Taheri MD (2), Mark W. Ball MD (3), Alan Meeker MD, PhD (2), Arthur Burnett MD (2), Rajni Sharma, PhD (2) , Alcides Chaux MD (6), George Netto, MD (1)

1. Department of Pathology, The University of Alabama at Birmingham, Birmingham, AL, USA
2. Department of Pathology, Johns Hopkins University, Baltimore, MD, USA
3. Department of Urology, Johns Hopkins University, Baltimore, MD, USA
4. Department of Oncology, Johns Hopkins University, Baltimore, MD, USA
5. Department of Pathology, George Washington University, Washington, DC, USA
6. Norte University, Asunción, Paraguay

**Running title:** PD-L1, CD8 and FOXP3 in primary and metastatic papillary RCC

**Corresponding Author:** George J. Netto, MD, Professor and Chair, Department of Pathology, The University of Alabama at Birmingham, WP Building, Suite P230 l 619 19th Street, South, Birmingham, AL 35249-7331. Phone: (205) 934-0014. Email: gnetto@uabmc.edu

**Keywords:** papillary RCC, kidney, PDL1, CD8, FOXP3, Ki-7.
